Krempa David
SEC insider (Form 3/4/5 filer). CIK 0001968254. Chief Business Officer at Eton Pharmaceuticals, Inc. (ETON). 27 reported Form 4/5 transactions since Sep 2024; latest on Oct 6, 2026. Located in DEERPARK, IL.
Companies Krempa David has filed insider reports for
- Eton Pharmaceuticals, Inc. (ETON): Officer, Chief Business Officer
Krempa David
CIK: 0001968254
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Eton Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (27 total)
- Oct 6, 2026ETON
Eton Pharmaceuticals, Inc.
SaleDirect4.2K shares at avg. $55.07$229K - Oct 2, 2026ETON
Eton Pharmaceuticals, Inc.
ExerciseDirect10.5K shares- - Aug 24, 2026ETON
Eton Pharmaceuticals, Inc.
ExerciseDirect25K shares at avg. $7.31$183K - Aug 24, 2026ETON
Eton Pharmaceuticals, Inc.
SaleDirect25K shares at avg. $65.07$1.6M - Jul 31, 2026ETON
Eton Pharmaceuticals, Inc.
AwardDirectCommon Stock
129K shares- - Jul 12, 2026ETON
Eton Pharmaceuticals, Inc.
ExerciseDirect10K shares- - May 27, 2026ETON
Eton Pharmaceuticals, Inc.
SaleDirect19.7K shares at avg. $31.47$619K - May 27, 2026ETON
Eton Pharmaceuticals, Inc.
ExerciseDirect12.5K shares at avg. $1.37$17K - May 27, 2026ETON
Eton Pharmaceuticals, Inc.
ExerciseDirect7.2K shares at avg. $3.58$26K - May 26, 2026ETON
Eton Pharmaceuticals, Inc.
SaleDirect37.5K shares at avg. $31.49$1.2M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 6, 2026 | ETON Eton Pharmaceuticals, Inc. | Sale | 4,166 | $55.07 | $229,406 | Direct |
| Oct 2, 2026 | ETON Eton Pharmaceuticals, Inc. | Exercise | 10,522 | - | $0 | Direct |
| Aug 24, 2026 | ETON Eton Pharmaceuticals, Inc. | Exercise | 25,000 | $7.31 | $182,750 | Direct |
| Aug 24, 2026 | ETON Eton Pharmaceuticals, Inc. | Sale | 25,000 | $65.07 | $1,626,750 | Direct |
| Jul 31, 2026 | ETON Eton Pharmaceuticals, Inc. | Award Common Stock | 128,985 | - | - | Direct |
| Jul 12, 2026 | ETON Eton Pharmaceuticals, Inc. | Exercise | 10,000 | - | $0 | Direct |
| May 27, 2026 | ETON Eton Pharmaceuticals, Inc. | Sale | 19,679 | $31.47 | $619,375 | Direct |
| May 27, 2026 | ETON Eton Pharmaceuticals, Inc. | Exercise | 12,476 | $1.37 | $17,092 | Direct |
| May 27, 2026 | ETON Eton Pharmaceuticals, Inc. | Exercise | 7,203 | $3.58 | $25,787 | Direct |
| May 26, 2026 | ETON Eton Pharmaceuticals, Inc. | Sale | 37,524 | $31.49 | $1,181,732 | Direct |
1-10 of 27 transactions